Pharmaceutical-grade ibogaine is produced using a Good Manufacturing Practice (GMP) extraction and manufacturing process designed to ensure consistent quality, purity, and safety. The process involves extracting the active compound, purifying it to pharmaceutical standards, and subjecting it to rigorous quality control testing throughout production.
By adhering to GMP requirements, manufacturers can produce ibogaine that meets the strict standards required for medical research, pharmaceutical development, and regulated therapeutic applications.
